Consumer staples remain one of the more resilient areas of the equity market, yet two ETFs that both target the sector can deliver quite different results. FXG and IYK illustrate the point clearly. One follows a factor-driven, modified equal-weight strategy, while the other sticks to straightforward market-cap weighting. For investors focused on sector exposure, fees, and risk management, the differences between these approaches matter.
FXG tracks the StrataQuant Consumer Staples AlphaDEX Index using a rules-based process that screens Russell 1000 consumer staples names for growth and value traits, then applies modified equal-dollar weighting. The fund typically holds around 41 positions and carries a noticeably larger mid-cap allocation than pure cap-weighted peers. Top holdings such as DAR, BG, PPC, MCK, INGR, CASY, and FRPT each receive low-to-mid single-digit weights, with the top 10 making up roughly 40% of assets. The expense ratio stands at 0.63%. Launched in 2007, it functions as a smart-beta vehicle that emphasizes valuation and growth factors.
IYK follows the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index on a market-cap-weighted basis. It generally holds 54 to 58 securities, with about 96% of assets in companies above $10 billion in market cap. The portfolio is anchored by names such as PG, KO, PM, PEP, CVS, MO, and MCK, where the top 10 account for roughly 66% of assets. Its expense ratio is approximately 0.38%. Launched in 2000, IYK delivers concentrated exposure to high-quality mega-cap staples names.
Both ETFs sit within the defensive consumer staples sector. Persistent inflation and higher input costs continue to pressure food and beverage margins, while companies rely on pricing power to offset them. The rise of GLP-1 weight-loss drugs has also introduced longer-term questions for packaged food demand, an issue that hits mid-cap names harder. At the same time, investors continue to favor dividend-paying, lower-volatility equities as rate expectations shift, which supports established large-cap franchises. These dynamics help explain why the two funds can move differently despite sharing the same broad sector label. I checked relative positioning using Tickeron’s AI Pattern Search Engine to confirm the exposure differences.
Recent cycles show IYK maintaining stronger relative momentum, backed by the scale, recurring revenue, and free-cash-flow strength of its mega-cap holdings. Its historically lower beta near 0.40 has helped limit drawdowns in risk-off periods. FXG has trailed, largely because of its heavier mid-cap weighting in food processors, agricultural products, and specialty retailers that face margin pressure and commodity volatility. While FXG’s more even weightings reduce single-name concentration, they also limit upside from the strongest performers. In my view, IYK currently offers concentrated defensive quality at a lower cost, whereas FXG supplies broader factor exposure at a higher fee and with added idiosyncratic risk. One thing that stands out is how these structural choices play out in the current environment.
Based on the structural factors outlined above, Tickeron’s AI currently favors IYK over FXG. IYK combines a lower expense ratio, lower beta, and concentrated exposure to mega-cap staples names that demonstrate durable pricing power and consistent trend strength. Although FXG provides more balanced weightings and value-factor diversification, its higher cost and greater exposure to margin-sensitive mid-cap food and agriculture companies have weighed on relative performance in recent periods. On balance, IYK’s combination of cost efficiency, quality, and defensive characteristics appears the stronger option right now.
I often turn to Tickeron’s AI Screener when comparing sector ETFs like these. The tool lets me filter across technical patterns, fundamentals, trends, and performance metrics in one place, which helps surface relative strength signals more quickly than manual review. It has become a regular part of my process for evaluating positioning and momentum between funds such as FXG and IYK.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
FXG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In 38 of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 73 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +1.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 259 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 176 of 272 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows